Bactolac Pharmaceutical, Inc. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of topical drug products. The company’s offerings span both prescription and over-the-counter categories, emphasizing aseptically compounded formulations for skin care, wound management and infection control. Bactolac’s manufacturing facilities are designed and operated under current Good Manufacturing Practices (cGMP) regulations, supporting both its in-house brands and contract manufacturing partnerships.
The company’s product portfolio includes topical antiseptics, first-aid antibiotic ointments, acne treatments and specialty dermatological preparations. Through proprietary manufacturing processes, Bactolac supplies municipally branded and private-label formulations to hospitals, nursing homes, pharmacies and retail channels. In addition to end-product manufacturing, the company offers development services for custom topical formulations, including analytical testing, stability studies and regulatory support for clients seeking to bring new products to market.
Founded in 1979 and headquartered in West Bridgewater, Massachusetts, Bactolac Pharmaceutical serves customers across North America and has relationships in select international markets. The company’s management team brings experience in pharmaceutical operations, quality assurance and regulatory affairs, guiding strategic investments in manufacturing capabilities and product development. With over four decades of topical formulation expertise, Bactolac continues to pursue growth through expanded contract manufacturing services and targeted product innovation.
AI Generated. May Contain Errors.
